Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatin-Reference-Cited by-同舟云学术

Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatin

Published:1994-05 Issue:14 Volume:73 Page:D42-D49
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Herd J.Alan,West M.Stewart,Ballantyne Christie,Farmer John,Gotto Antonio M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts;Blankenhorn;JAMA,1987

2. Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Quantitative arteriographic assessment of patients in NHLBI Type II study;Brown;Arteriosclerosis,1989

3. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up;Cashin-Hemphill;JAMA,1990

4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B;Brown;N Engl J Med,1990

5. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens;Kane;JAMA,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Dysfunctional Vascular Endothelial Cells Using Immunoliposomes Under Flow Conditions;Cellular and Molecular Bioengineering;2020-05-04

2. Fluvastatin for lowering lipids;Cochrane Database of Systematic Reviews;2018-03-06

3. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease;PPAR Research;2008

4. Fluvastatin, HMG-CoA Reductase Inhibitor: Antiatherogenic Profiles Through Its Lipid-Lowering-Dependent and -Independent Actions;Cardiovascular Drug Reviews;2006-06-07

5. Fluvastatin: efficacy and safety in reducing cardiac events;Expert Opinion on Pharmacotherapy;2005-09